Analyst Ratings for Codiak Biosciences Inc. (CDAK)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
9/1/2022 | Goldman Sachs » Updated 11/7/2022 |
Andrea Tan | Downgrade | Neutral (Buy) |
1.20 (2.00) |
2.24 (0.06) |
-97.32% | Details |
11/9/2020 | Wedbush » Updated 2/22/2022 |
David Nierengarten | New Coverage | Outperform (N/A) |
24.00 (34.00) |
9.09 (0.06) |
-99.34% | Details |